Brigatinib from Germany
Brigatinib is an ALK inhibitor for lung cancer treatment. This macrocyclic aromatic nitrogen-heterocycle drug substance imports under HTS 2933.99.75.00.
Duty Rate — Germany → United States
10%
Rate breakdown
9903.05.3910%Section 301 (forced labor) — European Union member state (col1 rate < 10 percent): MFN < 10% → total duty capped at 10%
Import Tips
• GMP compliance audit trail required from API manufacturer
• Residual solvent analysis per ICH Q3C mandatory for entry
• Avoid declaring as 'new chemical entity' after FDA approval